Rubicon Organics – Needs More Time for Ramp Up; Shifting Focus to 2027

To View the Complete Report

Author: Atrium Research November 16, 2026

Nicholas Cortellucci, CFA | Equity Research Analyst | [email protected] | 647-391-3314

Luca Perna | Equity Research Associate | [email protected] | 647-969-1027

PLEASE REVIEW THE DISCLOSURES AT THE BOTTOM OF THE PAGE

What you need to know:

  • ROMJ reported Q3 revenue of $18.3M (+17% YoY), and adjusted EBITDA of $1.4M came in below our estimates of $20.2M and $1.7M, respectively. This miss was due to the Cascadia ramp up being six months behind schedule.

  • Gross margin declined to 27.5% from 33.7% in Q3/25, weighed down by the costs of scaling the platform.

  • Cascadia contributed $2.3M of revenue in its first full quarter of sales, with management confident in reaching targeted yields at the facility by year-end.

This morning, Rubicon Organics Inc. (ROMJ:TSXV, ROMJF:OTCQX) reported its Q3 financials, which were lower than our estimates due to the Cascadia ramp up taking longer than expected. Management remains bullish on 2027, where the effects of its expansion and optimization efforts will be seen. Recently, CEO Margaret Brodie presented at Planet Microcap; watch the replay here. We are maintaining our BUY rating and $1.00/share target price on ROMJ.

Q3 Financial Highlights

  • Revenue came in at $18.3M (+17% YoY), below our estimate of $20.2M and CapitalIQ consensus of $20.3M. Product sales were $23.1M (+16% YoY), driven by Pacifica’s yields increasing 16% YTD.

  • Cascadia generated ~$2.3M of revenue in its first full quarter of contribution, or 12% of sales, up from 2% in Q2. Management stated that ramping Cascadia to optimal performance has taken longer than anticipated, but results from recent crops reinforced their view that it can achieve target yields by year-end.

  • ROMJ secured a top 10 market share position in Canada in Q3, while maintaining its position as #1 premium LP.

  • International markets represented 12% of Q3 net revenue as the program continued to ramp, with sales to the UK, Germany, and Australia.

  • Gross margin for the quarter was 27.5%, below our estimate of 36.0% and 29.5% in Q2. The lower margins were due to the costs of scaling its platform as well as a changing mix (more low-margin international sales).

  • Adj. EBITDA was $1.4M (8% margin) vs. our $1.7M, CapitalIQ consensus estimate of $2.1M, and $1.7M in Q3/25. Adj. EBITDA increased 27% QoQ even though Cascadia start-up costs were included for the first time ($1.3M). Operating expenses decreased 28% QoQ.

  • Rubicon reported a net loss of $0.1M compared to net income of $2.8M in Q3/25 (included a $2.8M fair value gain) and our estimate of $1.2M.

  • Operating cash flow was $3.8M, as A/P increased $3.0M QoQ.

  • Rubicon ended Q3 with $4.2M cash and $15.3M debt (down $0.3M QoQ). PF cash is $7.2M if we include the $3.0M private placement that closed in October.

Figure 1: Q3 Financials Summary

Q3/26A Atrium Est. YoY
Revenue ($M) $18.3 $20.2 +17%
Gross Margin (%) 27.5% 36.0% -619 bps
Adj. EBITDA ($M) $1.4 $1.7 -18%
EBITDA Margin (%) 8% 9% -328 bps
Net Income ($M) ($0.1) $1.2 N/A

Outlook Management stated that its focus going forward is translating the expanded platform into its financial results. The team believes ROMJ is making progress on initiatives to improve capacity, efficiency, and financial performance. Capacity increases are scheduled for 2027 from the new lighting solutions, pre-roll automation (installed August 2026), and hydrocarbon extraction moving in-house (ramp up in H1/27),

To view the complete report, click on the button above.

Related posts

Subscribe to Newsletter

Subscribe VBNG Newsletter for news. Let's stay updated!